Notably, the introduction of wild-type N1DARP, but not the N1DARP-20Y/34Y mutant, ameliorated USP10 overexpression-induced Notch signaling activation, as well as tumor stemness, chemoresistance, and progression (Supplementary Fig. S7i–l). Here, USP10 is linked to neoplasm.